Brain cancer remains one of the hardest cancers to treat, and researchers are under pressure to find therapies that do more than slow the disease for a short time. For patients with aggressive tumors ...

Western PhD grad Edith Otalike developed tool to assess participant data helping strengthen evidence used in health-care decisions.

Clinical conduct of both blarcamesine (ANAVEX®2-73) studies in healthy volunteers is now complete, data are expected to ...

Topline data readout from APPROACH Phase 3 study of HLP003 in development for the potential adjunctive treatment of major ...